baber/WOPTO huggingface dataset:
Patent DK-1607623-T3 (DK)
Inventor: ROCHHOLZ HERMANN DR-ING
IPC: F03D1/06
Filed: 2005-05-30
Granted: 2011-07-18
Abstract: Each rotor blade (1) has one or more drainage apertures (3) in one edge. There is a net, gauze or felt (2) which may soak up any water present in the hollow space adjacent to each drainage aperture. There is a handhold (4) in the end of the blade near the absorption body. Each of the drainage openings may have a diameter of 5 mm.
Patent DK-1602370-T3 (DK)
Inventor: WEBB RANDY LEE
IPC: A61K31/506
Filed: 2001-11-15
Granted: 2008-09-22
Abstract: A pharmaceutical composition comprising the renin inhibitor aliskiren or a pharmaceutically acceptable salt thereof and at least one therapeutic agent selected from the group consisting of a diuretic or a pharmaceutically acceptable salt thereof, and a carrier
Patent DK-1760088-T3 (DK)
Inventor: DENGJEL JOERN
IPC: C07K14/47
Filed: 2005-09-05
Granted: 2008-06-09
Abstract: The present invention relates to immunotherapeutic methods, and molecules and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides, that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the present invention relates to 49 novel peptide sequences derived from HLA class II molecules of human tumour cell lines which can be used in vaccine compositions for eliciting anti-tumour immune responses.
Patent DK-1615014-T3 (DK)
Inventor: MAGYAR GEORGES
IPC: G01N35/00
Filed: 2005-07-05
Granted: 2009-01-19
Abstract: Liquid sample sampling device has an evacuation orifice (22) connected to tubular needles (31, 32). A vent nozzle (13) and a central conduit (23) are connected to a tubular needle (33) between the needles (31, 32). The end of the needle (33) is placed inside a sample flask (2), above the ends (41, 42) of the needles (31, 32). The orifice determines a desired level (3) of a liquid sample in the flask. An independent claim is also included for a process of cleaning the above liquid sample sampling device.
Patent DK-1759001-T3 (DK)
Inventor: CRINE PHILIPPE
IPC: A61K47/64
Filed: 2005-04-21
Granted: 2011-08-01
Abstract: The invention relates to a pharmaceutical composition comprising a bone delivery conjugate having the structure Z-sALP-Y-Dn-X, wherein X is absent or is an amino acid sequence of at least one amino acid; Y is absent or is an amino acid sequence of at least one amino acid; Z is absent or is an amino acid sequence of at least one amino acid; Dn is a poly aspartate, wherein n=10 to 16; and sALP is a soluble alkaline phosphatase and uses thereof.
Patent DK-1746980-T3 (DK)
Inventor: ANSTETT-KLEIN ISABEL
IPC: A61K9/50
Filed: 2005-05-04
Granted: 2012-01-30
Abstract: A manufacturing process for production of dosage forms for oral administration of active ingredients is described.
Patent DK-1746928-T3 (DK)
Inventor: YU YIHUA
IPC: A61B5/00
Filed: 2005-05-17
Granted: 2012-05-21
Abstract: A sensor for the in vivo detection of glucose comprises: components of an assay for glucose, a readout of which is a detectable optical signal which can be interrogated transcutaneously by external optical means when the sensor is implanted in vivo; and a shell of biodegradable material encapsulating the assay components while allowing analyte to contact the assay components, wherein the biodegradable material comprises a co-polymer having hydrophobic and hydrophilic units. A method of preparing such a sensor preferably comprises coacervation, solvent evaporation and/or extraction, spray drying, spray coating, spray chilling, rotary disk atomisation, fluid bed coating, coextrusion and/or pan coating. A method of detecting glucose using such a sensor suitably comprises implantation of the sensor into the skin of a mammal, transdermal detection or measurement of glucose using external optical means and degradation of the biodegradable material.
Patent DK-1864660-T3 (DK)
Inventor: NUIJEN BASTIAAN
IPC: A61K9/20
Filed: 2002-11-01
Granted: 2011-02-21
Abstract: An anti-cancer formulation comprising: 5-(1-azaridinyl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione (EO9) and a buffered formulation vehicle comprising tert-butanol/water. There is also discloses a method of preparing a formulation comprising 5-(1-azaridinyl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione (EO9), which method comprises preparing a formulation comprising 5-(1-azaridinyl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione (EO9) and a buffered formulation vehicle comprising tert-butanol/water, and lyophilising the formulation to give a lyophilisate.
Patent DK-1945167-T3 (DK)
Inventor: BASTHOLM JEPPE CHRISTIAN
IPC: A61G7/10
Filed: 2006-11-09
Granted: 2009-08-31
Abstract: An actuator system, preferably for patient lifters, includes at least one actuator driven by an electric motor, a control unit having a power limiting circuit, and at least one handset having a plurality of keys. The actuator system is arranged such that the threshold value of the maximum permissible power in the power limiting circuit may be changed, and that this change may be performed via a key on the handset. Thus, it is possible to subsequently adjust the cutout limit safely and easily via a key on a handset, so that the cutout limit may be adapted to the actual application into which the actuator system is to be incorporated. For reasons of safety, it is preferred to use a separate handset for changing the threshold value.
Patent DK-2041991-T3 (DK)
Inventor: LORENZEN ROLF
IPC: H04W24/08
Filed: 2007-07-10
Granted: 2011-01-24
Abstract: A method and a system for determining the dependence between several device-parameter values in each case of at least one device parameter of a mobile telephone (31, 32, . . . , 3m, 3n) and at least one signal parameter of a signal transmitted and/or received by the mobile telephone (31, 32, . . . , 3m, 3n) adjusts several device-parameter values within a mobile telephone (31, 32, . . . , 3m, 3n) of at least one device parameter of the respective mobile telephone (31, 32, . . . , 3m, 3n) for a given number of frequencies of the respectively transmitted and/or received signal, and measures the associated signal parameters of a signal transmitted and/or received by the respective mobile telephone (31, 32, . . . , 3m, 3n). All of the frequencies and the device-parameter values of at least one device parameter respectively associated with every frequency are present in the respective mobile telephone (31, 32, . . . , 3m, 3n) at the start of the measurements.
Patent DK-2006979-T3 (DK)
Inventor: EBI GUENTER DR
IPC: H02K7/00
Filed: 2008-05-29
Granted: 2011-05-16
Abstract: The method involves protruding a complete rotor shaft (1) from a middle rotor bundle (2), having grooves for receiving a winding, and from two coaxial shaft ends (3, 3 ') of smaller diameters. One end of the middle rotor bundle is reduced by a material space by forming the shorter rotor bundle, and the shaft end (3) corresponding to original shape of the shaft end (3') is molded through the material space at the end of the rotor shaft. An excess remaining of the rotor shaft is finally disconnected.
Patent DK-2883449-T3 (DK)
Inventor: MCWHIRTER JOHN
IPC: C12N15/85
Filed: 2013-03-15
Granted: 2018-04-23
Abstract: A genetically modified non-human animal is provided, wherein the non-human animal expresses an antibody repertoire capable of pH dependent binding to antigens upon immunization. A genetically modified non-human animal is provided that expresses a single light chain variable domain derived from a single rearranged light chain variable region gene in the germline of the non-human animal, wherein the single rearranged light chain variable region gene comprises a substitution of at least one non-histidine encoding codon with a histidine encoding codon. Methods of making non-human animals that express antibodies comprising a histidine-containing universal light chain are provided.
Patent DK-3483183-T3 (DK)
Inventor: GOVINDAN SERENGULAM V
IPC: G01N33/532
Filed: 2003-03-03
Granted: 2021-06-21
Abstract: This invention relates to an immunoconjugate comprising (i) a humanized antibody comprising the heavy chain CDR (complementarity determining region) sequences CDR1 (NYGMN); CDR2 (WINTYTGEPTYTDDFKG) and CDR3 (GGFGSSYWYFDV), and the light chain CDR sequences CDR1 (KASQDVSIAVA); CDR2 (SASYRYT); and CDR3 (QQHYITPLT) and human antibody framework region (FR) sequences, wherein the FR sequences comprise substituted murine amino acid residues found at a corresponding location in amino acid residues 38, 46, 68 and 91 of the murine heavy chain variable region of Fig. 3B and amino acid residue 20, 60, 85 and 100 of the murine light chain variable region of Fig 3A, wherein the humanized antibody is conjugated to (ii) a drug.
Patent DK-0433135-T3 (DK)
Inventor: GROSIUS PAUL
IPC: C07B61/00
Filed: 1990-12-05
Granted: 1995-04-03
Abstract: A compound (I) is prepared by reacting at least one (meth)acrylate (II) with a heterocyclic alcohol (III) in the presence of at least one catalyst chosen from tin dialkyloxides and/or tin dialkyldialkoxides. 
<??>Alkylimidazolidone acrylates and methacrylates are known for the part they play in the constitution of polymers which are useful as coatings and adhesives and for paper and textile treatment, as well as for their use as leather treatment agents and in the production of emulsion paints. 
<IMAGE>
 R1 = H, CH3; A,B = alkylene group with a straight or branched chain containing from 2 to 5 carbon atoms.
Patent DK-0528920-T3 (DK)
Inventor: CAPY GILBERT
IPC: B29C53/24
Filed: 1991-04-25
Granted: 1995-07-24
Abstract: The device includes a toothed wheel on which pleats of a sheet 10 are preformed, in some cases with the aid of a second toothed wheel 31, and a device for holding by a vacuum; then the preformed pleats are transferred to a pleat gathering wheel 13 either directly or through the medium of a pleat pressing wheel, where they are laid down then fixed to form a pleated sheet 23. The toothed wheels 5 and 31 and the pleat pressing wheel and/or the pleat gathering wheel 13 can be arranged to produce areas with no pleats at regular intervals.
Patent DK-0536194-T3 (DK)
Inventor: PAYNE GEOFFREY LAURENCE
IPC: C02F1/54
Filed: 1991-06-20
Granted: 1995-06-26
Abstract: An aqueous suspension of coagulatable material is coagulated by adding polymeric coagulant to the suspension and then separating the resultant coagulated material from the liquor. The coagulatable material may be present in the aqueous suspension as a suspension of suspended solids or as colloidally dispersed solids. The suspension may be coal tailings or other aqueous (generally mineral) suspension. The polymeric material must be a low molecular weight, highly ionic, polymeric material. It is added to the aqueous suspension while in the form of polymeric particles having a size mainly above 30  mu m and that will dissolve into the suspension and coagulate the coagulatable material. A counterionic, high molecular weight, flocculant is generally added subsequently in order to flocculate the coagulated material.
Patent DK-0550621-T3 (DK)
Inventor: FORTUNAK JOSEPH MARIAN
IPC: C07D471/14
Filed: 1991-09-23
Granted: 1999-07-26
Abstract: A method for making 8-methyl-7-(1-oxopropyl)indolizino[1,2-b]quinolin-9(11H)-ones from 4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-3,14(4 H,12H)-diones, said method being graphically illustrated as follows: <IMAGE> +TR  <IMAGE>
Patent DK-0503648-T3 (DK)
Inventor: WALLNER BARBARA P
IPC: C07K16/28
Filed: 1992-03-12
Granted: 2000-10-30
Abstract: Polypeptides and proteins comprising the CD2-binding domain of LFA-3 are disclosed. DNA sequences that code on expression for those polypeptides and proteins, methods of producing and using those polypeptides and proteins, and therapeutic and diagnostic compositions are also disclosed. Deletion mutants unable to bind CD2 and methods for their use are also disclosed. In addition, fusion proteins which comprise the CD2-binding domain of LFA-3 and a portion of a protein other than LFA-3, DNA sequences encoding those fusion proteins, methods for producing those fusion proteins, and uses of those fusion proteins are disclosed.
Patent DK-0578914-T3 (DK)
Inventor: WINNIKE DON
IPC: F16K5/06
Filed: 1993-03-11
Granted: 1996-02-12
Abstract: A valve seat arrangement sealing against a valve core (26) in a valve, particularly for a ball valve, having an inner ring (70) with a first deflectable sealing lip (80) and an outer ring (68) with a second deflectable sealing lip. The first deflectable lip is arranged to protrude forwardly to make initial contact with a closing valve core and once deflected, the second lip is arranged to land against said closing valve core forming a secondary seal. The first sealing lip and the second sealing lip are fashioned having selectively angled beveled surfaces facing the core. The invention provides an effective sealing arrangement for high temperature service. <IMAGE>
Patent DK-0583726-T3 (DK)
Inventor: BOEDECKER BERND
IPC: A61K9/16
Filed: 1993-08-11
Granted: 1996-12-09
Abstract: Micropellet cores which contain pancreatin and can be coated with an enteric film and which have a spherical or ellipsoidal shape, where the diameter of the sphere or the minor axis is in the range 0.7-1.4 mm, in particular 0.8-1.2 mm, and which have a particle size distribution in which at least 80 % of the micropellet cores have a ratio of the minor axis to the major axis in the range from 1:1 to 1:2, are described. Also described is a process for the production of these pancreatin micropellets.
Patent DK-0636259-T3 (DK)
Inventor: BOEBERT WILLIAM E
IPC: G06F21/31
Filed: 1993-04-15
Granted: 1997-07-07
Abstract: A data communication system providing for the secure transfer and sharing of data via a local area network and/or a wide area network. The system includes a secure processing unit which communicates with a personal keying device and a crypto media controller attached to a user's workstation. The communication between these processing elements generates a variety of data elements including keys, identifiers and attributes. The data elements are used to identify and authenticate the user, assign user security access rights and privileges, and assign media and device attributes to a data access device according to a predefined security policy. The data elements are manipulated, combined, protected and distributed through the network to the appropriate data access devices, which prevents the user from obtaining unauthorized data. <IMAGE>
Patent DK-0647287-T3 (DK)
Inventor: ENSIGN DONALD EUGENE
IPC: B32B7/00
Filed: 1993-06-10
Granted: 1999-02-08
Abstract: A method and apparatus for drying of a cellulosic fibrous structure having constant basis weight and/or density or multiple regions varying in basis weight and/or density. Such a cellulosic fibrous structure may have a nonuniform moisture distribution prior to drying by the disclosed method and apparatus. An equally or more uniform moisture distribution is achieved by providing a micropore medium in the air flow path which has a greater flow resistance than the interstices between the fibers in the cellulosic fibrous structure web. The micropore medium is the limiting orifice in the air flow used in the drying process. The micropore medium may be executed in a laminate of plural laminae, each of successively increasing or decreasing pore size. This arrangement provides the advantage that minimal sagging or deformation of each lamina into the next coarser lamina occurs and lateral air flow between the micropore medium and the cellulosic fibrous structure is reduced. The micropore medium may be disposed either upstream or downstream in the air flow path of the cellulosic fibrous structure to be through-air dried.
Patent DK-0651789-T3 (DK)
Inventor: CALANDRA GARY B
IPC: A61K39/00
Filed: 1993-07-13
Granted: 2002-03-11
Abstract: Herpes Zoster, or varicella related post herpetic neuralgia is alleviated by immunizing people at risk of developing herpes zoster with varicella zoster virus (VZV) antigen.
Patent DK-0608747-T3 (DK)
Inventor: BLUM JOERG DR-ING
IPC: B21C37/26
Filed: 1994-01-18
Granted: 1997-03-17
Abstract: The invention relates to a method and an apparatus for wrapping tubes (1), preferably of oval or elliptical cross-section, with strip (2) which is drawn off from a reel and wound helically onto the rotated tube (1) perpendicularly to the surface of the tube and with a deformation which increases from the bottom edge to the top edge. In order to shift the neutral axis of the strip (2) to be wound on towards the top edge, the strip (2) is provided, before running onto the tube (1), with indentations (5) that start from the bottom edge and reduce the deformation resistance in the region of the bottom of the strip (2) in those sections of the strip which are drawn onto the surface of the tube at the greatest radial distance from the longitudinal axis of the tube and with the smallest radius of curvature. <IMAGE>
Patent DK-0680496-T3 (DK)
Inventor: SINGH BALWANT
IPC: C08L51/04
Filed: 1994-01-21
Granted: 1997-04-14
Abstract: Novel resin compositions are provided which possess excellent heat resistance and thermal color stability, alone, or in admixture with bulk resins. The claimed resin compositions comprise homo- and/or copolymers of N-(2,3-dimethylphenyl) maleimide, alone, or in further combination with resins composed of copolymer components, such as vinyl copolymers and rubber-grafted vinyl copolymer resins. The resin compositions have improved heat resistance and produce molded articles with desirably light colors. Also provided is an improved process to make maleimide monomers by using selected polar solvents whereby the amount of uncyclizable trans-amic acid is held at tolerable levels and the desired maleimide is obtained in high yields, free from by-products.
Patent DK-0710274-T3 (DK)
Inventor: GEKE JUERGEN
IPC: C11D3/33
Filed: 1994-07-12
Granted: 1998-05-11
Abstract: PCT No. PCT/EP94/02285 Sec. 371 Date Jan. 22, 1996 Sec. 102(e) Date Jan. 22, 1996 PCT Filed Jul. 12, 1994 PCT Pub. No. WO95/03389 PCT Pub. Date Feb. 2, 1995Powdered, paste, or liquid media for cleaning and/or degreasing hard surfaces, especially surfaces of organic polymers (PVC) contain active ingredients of amino acids, carboxylic acids, and nonionic surfactants, possibly supplemented by action-reinforcing auxiliaries and/or demulsifying additives. Processes using these media are also claimed.
Patent DK-0708935-T3 (DK)
Inventor: SOUPARIS HUGES
IPC: G03H1/02
Filed: 1995-05-10
Granted: 2005-09-19
Abstract: PCT No. PCT/FR95/00615 Sec. 371 Date Feb. 24, 1997 Sec. 102(e) Date Feb. 24, 1997 PCT Filed May 10, 1995 PCT Pub. No. WO95/31756 PCT Pub. Date Nov. 23, 1995The present invention relates to a procedure for irreversibly transferring a diffraction grating, such as a stamped hologram, onto a substrate, such as a document or a product to be secured, which procedure consists of preparing a transfer film consisting of a supporting film substrate that carries at least one layer formed by a protective film overlay, a metallized or transparent reflective layer that carries the stamped optical image, and a layer of activatable adhesive. The procedure consists of superimposing the transfer film prepared in the above-described manner and of applying pressure with a transfer tool. The stage consisting of the preparation of the transfer film consists of depositing, onto a supporting film substrate whose dimensions are greater than those of the element to be transferred, at least one optical element whose dimensions correspond exactly to those of the element to be transferred onto the substrate. The transfer tool acts on a portion of the transfer film whose dimensions are greater than those of the surface that corresponds to the element to be transferred. The invention also relates to a transfer film and to a tool for the implementation of the procedure.
Patent DK-0763037-T3 (DK)
Inventor: LAUFER STEFAN
IPC: C07D517/04
Filed: 1995-05-31
Granted: 2002-03-04
Abstract: PCT No. PCT/EP95/02079 Sec. 371 Date Mar. 28, 1997 Sec. 102(e) Date Mar. 28, 1997 PCT Filed May 31, 1995 PCT Pub. No. WO95/32972 PCT Pub. Date Dec. 7, 1995The present invention relates to heterocyclic compounds of the formula in which R1-R7, B, a and X have the meanings recited in the specification. These compounds are usable in the treatment of diseases of the rheumatoid group and for the prevention of allergically induced diseases.
Patent DK-0804558-T3 (DK)
Inventor: RASMUSSEN GRETHE
IPC: C12R1/19
Filed: 1995-11-08
Granted: 2008-05-26
Abstract: The present invention relates to isolated nucleic acid sequences encoding polypeptides having tripeptide aminopeptidase activity. The invention also relates; to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as recombinant methods for producing the polypeptides.
Patent DK-0799516-T3 (DK)
Inventor: MAYER KARL-HEINZ
IPC: H02H9/04
Filed: 1995-12-21
Granted: 1999-02-08
Abstract: The electrical circuit breaker has a main line (terminals 41, 42) to be protected, a test circuit (terminals 43, 44), a test key (2) and an electrical signalling device (49). The electrical signalling device (49) is situated in the housing (3, 4) of the circuit breaker and can be connected to the test circuit and thus activated via a switch (45, 47). This switch (45, 47) is coupled (tongue 55) to the test key (2) and is opened by pressing the test key (2). In this position the test key (2) interlocks (46, 57) with the switching mechanism (59) of the circuit breaker and is not released until the circuit breaker has been switched on again by operating the switching mechanism (59).
Patent DK-0876168-T3 (DK)
Inventor: FRANCHI PIERRE
IPC: A61M60/843
Filed: 1996-12-30
Granted: 2002-11-25
Abstract: PCT No. PCT/FR96/02104 Sec. 371 Date Jan. 27, 1999 Sec. 102(e) Date Jan. 27, 1999 PCT Filed Dec. 30, 1996 PCT Pub. No. WO97/26929 PCT Pub. Date Jul. 31, 1997The pump comprises: an essentially rigid body open at both ends and designed to be inserted in the down aorta artery; a flexible and elastic membrane (18) in the form of a sleeve connected in sealed manner to the body at the periphery of the ends thereof so as to define firstly, between the body and the sleeve, a closed intermediate space (20) of variable volume, and secondly, inside the sleeve, a variable volume (22) through which the blood to be pumped passes; and means for connecting the intermediate space to a source of hydraulic fluid suitable for causing the membrane to pass from a free state to a tensioned state in which it is urged radially inwards, thereby correspondingly reducing the volume through which the blood passes, and vice versa. According to the invention, between the ends of the body, the membrane is freely movable relative to the body; and the membrane has at least three longitudinal stiffener elements (36) uniformly distributed around the periphery of the membrane, said stiffener elements being suitable for locally reducing the longitudinal elasticity of the membrane, imposing a star-shape to the right section of the membrane in the tensioned state, which shape develops progressively between each end region and the middle region, said star-shape leaving a residual volume without the membrane coming into contact against itself.